Oncology: An Annotated Bibliography of Recent Literature
Authors: ONCOLOGY COMMITTEE*, MEDICAL KNOWLEDGE SELF-ASSESSMENT PROGRAM V
Journal: Annals of Internal Medicine (1979)

The Literature of Medicine1 June 1979Oncology: An Annotated Bibliography of Recent LiteratureReferences to Journal Articles and Other PapersONCOLOGY COMMITTEE*, MEDICAL KNOWLEDGE SELF-ASSESSMENT PROGRAM VONCOLOGY COMMITTEE*, MEDICAL KNOWLEDGE SELF-ASSESSMENT PROGRAM VSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-90-6-996 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptThis bibliography includes references to 79 recently published journal papers and similar sources that represent recent developments important in the concepts and practice of internal medicine. It has been compiled as a part of the work of the Oncology Committee toward the preparation of the Medical Knowledge Self-Assessment Program V Syllabus.In preparing this bibliography, the committee reviewed MEDLINE†bibliographic printouts of journal articles published since the beginning of 1975 and also drew on its own files. Consideration was given to availability of sources in libraries of hospitals and other clinical institutions in the United States and Canada; thus, only...Risk Factors Cancer Biology Principles of Diagnosis and Staging Principles of Cancer Treatment RADIOTHERAPY MULTI-MODAL PRIMARY TREATMENT Clinical Pharmacology Management of Selected Cancers BREAST CANCER LEUKEMIAS HODGKIN'S DISEASE NON-HODGKIN'S LYMPHOMAS MYELOMA AND OTHER DYSPROTEINEMIAS LUNG CANCER GASTROINTESTINAL CANCERS CANCERS OF THE GENITOURINARY SYSTEM BONE AND SOFT-TISSUE SARCOMAS BRAIN TUMORS ENDOCRINE TUMORS Management of the Manifestations of Cancer COMPLICATIONS NUTRITIONAL SUPPORT MANAGEMENT OF THE PATIENT AND THE FAMILY1. BARALLARSSONMATTSSON ELB: Breast cancer following irradiation of the breast. Cancer 40:2905-2910, 1977 Over 1000 women treated with ionizing radiation for nonneoplastic conditions of the breast had a fourfold increase in incidence of breast cancer. Implications are discussed. CrossrefMedlineGoogle Scholar2. HIROHATA T: Radiation carcinogenesis. Semin Oncol 3:25-34, 1976 A brief but thorough review of radiation carcinogenesis. MedlineGoogle Scholar3. MODANRONWERNER BEA: Thyroid cancer following scalp irradiation. Radiology 123:741-744, 1977 A sixfold increase in thyroid cancer was observed in more than 11 000 persons irradiated for tinea capitis. The significance of low level radiation is discussed. CrossrefMedlineGoogle Scholar4. RAPP F: Viruses as an etiologic factor in cancer. Semin Oncol 3:49-63, 1976 Summary of the current state of viral oncology, with the biochemical and biologic information necessary to understand the subject. MedlineGoogle Scholar5. DEVITAYOUNGCANELLOS VRG: Combination versus single agent chemotherapy: a review of the basis for selection of drug treatment of cancer. Cancer 35:98-110, 1975 A concise but highly informative discussion of therapeutic concepts incorporated in the development of combination chemotherapy regimens. Authors discuss the importance of initial tumor burden and cell kinetics as well as mechanisms of tumor resistance that drug combinations are designed to overcome. CrossrefMedlineGoogle Scholar6. FIALKOW P: The origin and development of human tumors studied with cell markers. N Engl J Med 291:26-35, 1974 Describes the results of studies of genetic marker mosaicism, chromosomal analyses, and disorders of immunoglobin synthesis that have contributed to our understanding of the clonogenic origin of tumors. CrossrefMedlineGoogle Scholar7. GELDERREESEMOOSSAHALLHUNTER FCATR: Purification, partial characterization, and clinical evaluation of a pancreatic oncofetal antigen. Cancer Res 38:313-324, 1978 Pancreatic oncofetal antigen, a new tumor marker, is well characterized in this report. It has limited specificity for pancreatic cancer but differs chemically from carcinoembryonic antigen, with which it may have additive clinical value. MedlineGoogle Scholar8. GEWIRTZYALOW GR: Ectopic ACTH production in carcinoma of the lung. J Clin Invest 53:1022-1032, 1974 "Big" ACTH can be measured in patients with all histologic forms of lung cancer but without Cushing's syndrome. CrossrefMedlineGoogle Scholar9. ROSENWEINTRAUBVAITUKAITISSUSSMANHERSHMANMUGGIA SBJHJF: Placental proteins and their subunits as tumor markers. Ann Intern Med 82:71-83, 1975 Detailed review of the application of human chorionic gonadotropin and its alpha and beta subunits, and other placental proteins, to diagnosis and follow-up of nongestational forms of malignancy. Methods for measuring placental alkaline phosphatase are presented and its clinical usefulness discussed. LinkGoogle Scholar10. SILVERYOUNGHOLLAND RRJ: Some new aspects of modern cancer chemotherapy. Am J Med 63:772-787, 1977 An excellent review of the general concepts of tumor cell kinetics, with detailed discussion of the importance of cell cycle, growth fraction, and doubling times for response to chemotherapy. Newer methods for the study of kinetics, flow microfluorometry, and high-speed scintillation autoradiography are briefly presented. CrossrefMedlineGoogle Scholar11. WALDMANNMCINTIRE TK: The use of a radioimmunoassay for alpha-fetoprotein in the diagnosis of malignancy. Cancer 34:1510-1515, 1974 Review of the usefulness of alpha-fetoprotein in the diagnosis of follow-up monitoring of patients with hepatoma, germ cell neoplasms, and other malignancies. CrossrefGoogle Scholar12. ZAMCHECK N: The present status of carcinoembryonic antigen (CEA) in diagnosis, detection of recurrence, prognosis and evaluation of therapy of colonic and pancreatic cancer. Clin Gastroenterol 5:625-638, 1976 The author places this controversial tumor marker in excellent clinical perspective, emphasizing both positive aspects and limitations. Investigative applications of carcinoembryonic antigen measurement, in pancreatic duct fluid and in effusions, are presented. CrossrefMedlineGoogle Scholar13. BASSETTSTECKEL LR: Imaging techniques in the detection of metastatic disease. Semin Oncol 4:39-52, 1977 Concise summary of technology available to stage patients in a systematic manner using radiology and radioisotope scanning. Ultrasonography and computed tomography scanning are mentioned briefly. MedlineGoogle Scholar14. DAVIS D: CT in the diagnosis of supratentorial tumors. Semin Roentgenol 12:97-108, 1977 Computed tomography for diagnosing brain tumors is discussed, and the differential diagnostic features of abscesses, extrinsic tumors, and vascular abnormalities are presented. CrossrefMedlineGoogle Scholar15. DEMEESTERBEKERMANJOSEPHTOSCANOGOLOMBBITRANGROSSSKINNER TCJMHJND: Gallium-67 scanning for carcinoma of the lung. J Thorac Cardiovasc Surg 72:699-708, 1976 Gallium-67 scanning has high accuracy in detecting carcinoma of lung and is useful in preoperative staging of the disease. CrossrefMedlineGoogle Scholar16. GERBERGOODREAUKIRCHNERFOUTY FJPW: Efficacy of pre-operative and postoperative bone scanning in the management of breast carcinoma. N Engl J Med 297:300-303, 1977 Describes use of sequential bone scans in the detection of bone metastases in women with breast cancer. CrossrefMedlineGoogle Scholar17. NYSTROMWEINERHEFFELFINGER-JUTTNERIRWINBATEMANWOLF JJJLJR: Metastatic and histologic presentations in unknown primary cancer. Semin Oncol 4:53-58, 1977 Retrospective analysis of 264 cases presenting as "unknown primary cancer, " emphasizing the difficulties encountered in searching for the source of metastases. MedlineGoogle Scholar18. KAPLAN H: Radiotherapeutic advances in the treatment of neoplastic disease. Isr J Med Sci 13:808-814, 1977 A comprehensive review, by a pioneer and leader in modern radiotherapy, covering not only the curative possibilities of radiation therapy in many primary sites but also the future potentials. MedlineGoogle Scholar19. HASKELL C: Immunologic aspects of cancer chemotherapy. Annu Rev Pharmacol Toxicol 17:179-195, 1977 Concise, up-to-date review of immunologic aspects of cancer that serve as the basis for immunotherapy and review of the leading trials testing the tenets of immunotherapy. CrossrefMedlineGoogle Scholar20. ROSENHUVOSMOSENDEBEATTIEEXELBYCAPPAROSMARCOVE GACEPBR: Chemotherapy and thoracotomy for metastatic osteogenic sarcoma. A model for adjuvant chemotherapy and the rationale for timing of thoracic surgery. Cancer 41:841-849, 1978 The latest of papers indicating an advantage in resection of pulmonary metastases when the tumor doubles at a slow rate, either alone or before systemic chemotherapy. The discussion is of osteogenic sarcoma, but the principles apply to other tumors. CrossrefMedlineGoogle Scholar21. SCHABEL F: Rationale for adjuvant chemotherapy. Cancer 39(suppl):2875-2882, 1977 Excellent review of the biologic basis for managing micrometastatic disease based on a great deal of experimental evidence developed by the authors in a variety of tumors in animals. CrossrefMedlineGoogle Scholar22. CHABNERMYERSCOLEMANJOHNS BCCD: The clinical pharmacology of antineoplastic agents. N Engl J Med 292:1107-1113, 1159-1168, 1975 Systematic and concise analysis of the clinical pharmacology of antineoplastic agents with special attention to pharmacokinetics, drug interaction, and clinical toxicity. See also reference 5 under Cancer Biology. CrossrefMedlineGoogle Scholar23. BONADONNAROSSIVALAGUSSABANFIVERONESI GAPAU: The CMF program for operable breast cancer with positive axillary nodes. Updated analysis on the disease-free interval, site of relapse and drug tolerance. Cancer 39(suppl):2904-2915, 1977 Update of a controlled trial of adjuvant combination chemotherapy. CrossrefMedlineGoogle Scholar24. HASKELLSPARKSGRAZEKORENMAN CFPS: Systemic therapy for metastatic breast cancer. Ann Intern Med 86:68-80, 1977 Review of options for systemic therapy. LinkGoogle Scholar25. LEGHADAVISMUGGIA SHF: Hormonal therapy of breast cancer: New approaches and concepts. Ann Intern Med 88:69-77, 1978 Review of hormonal treatments, including estrogen receptor antagonists. LinkGoogle Scholar26. MCGUIREHORWITZZAVAGAROLACHAMNESS WKDRG: Hormones in breast cancer: Update 1978. Metabolism 27:487-501, 1978 Comprehensive update of the status of hormone receptor proteins. CrossrefMedlineGoogle Scholar27. CANELLOS G: Chronic granulocytic leukemia. Med Clin North Am 60:1001-1018, 1976. Comprehensive review of the disease. CrossrefMedlineGoogle Scholar28. GEHANSMITHFREIREICHBODEYRODRIGUEZSPEERMCCREDIE ETEGVJK: Prognostic factors in acute leukemia. Semin Oncol 3:271-282, 1976 A statistical analysis of risk factors. MedlineGoogle Scholar29. HUMPHREYLANKFORD GJ: Acute leukemia: the use of surface markers in classification. Semin Oncol 3:243-251, 1976 An introduction to a new area. MedlineGoogle Scholar30. RAISAWITSKYCRONKITECHANANALEVYPASTERNACK KAEARB: Clinical staging of chronic lymphocytic leukemia. Blood 46:219-243, 1975 A useful staging classification using routine blood counts and clinical findings. CrossrefMedlineGoogle Scholar31. SIMONE J: Acute lymphocytic leukemia in childhood. Semin Hematol 11:25-39, 1974 A comprehensive review of the disease. MedlineGoogle Scholar32. BROGADIRFIALKCOLEMANVINCIGUERRADEGNANPASMANTIERSILVER SMMVTMR: Morbidity of staging laparotomy in Hodgkin's disease. Am J Med 64:429-433, 1978 An excellent review of the morbidity of staging laparotomy for Hodgkin's disease at several types of institutions. Thirty-seven percent of patients had major and minor complications; no mortality was noted. CrossrefMedlineGoogle Scholar33. GLATSTEIN E: Radiotherapy in Hodgkin's disease. Past achievements and future progress. Cancer 39(suppl):837-842, 1977 A very concise and excellent review of the evolution of radiotherapy in Hodgkin's disease, including some recommendations on current practice. CrossrefMedlineGoogle Scholar34. KAPLANROSENBERG HS: The management of Hodgkin's disease. Cancer 36(suppl):796-803, 1975 A distillation of the views of two experienced clinicians in the management of Hodgkin's disease, with heavy emphasis on radiotherapy. CrossrefMedlineGoogle Scholar35. LE FLOCHDONALDSONKAPLAN OSH: Pregnancy following oophoropexy and total nodal irradiation in women with Hodgkin's disease. Cancer 38:2263-2268, 1976 Two thirds of women reported in this review have had return of ovarian function; nine have become pregnant, and eight have been delivered of babies. However, the minimum radiation dose to the ovaries was 350 to 400 rads, raising the question of later complications. CrossrefMedlineGoogle Scholar36. THOMASPECKHAM PM: The investigation and management of Hodgkin's disease in the pregnant patient. Cancer 38:1443-1451, 1976 How to manage the pregnant patient with Hodgkin's disease is an often asked question. Most reports in literature are single case reports; these authors report a more extensive experience, including alterations in staging, and treatment based on pregnancy. CrossrefMedlineGoogle Scholar37. YOUNGANDERSONDEVITA RTV: The treatment of Hodgkin's disease: emphasizing programs at the Clinic Center, National Institutes of Health. Curr Probl Cancer 1(7):1-29, 1977 Up-to-date review on the management of Hodgkin's disease from diagnosis through treatment, with a useful discussion of the pros and cons of staging laparotomy. CrossrefMedlineGoogle Scholar38. BRAYLANJAFFEBERARD REC: Malignant lymphomas: current classification and new observations. Pathol Annu 10:213-270, 1975 Very comprehensive, yet readable, well-illustrated review of the classifications extant for both Hodgkin's disease and non-Hodgkin's lymphoma, with an evaluation and integration of the new information on lymphoid cell surfact markers. MedlineGoogle Scholar39. FISHERDEVITAJOHNSONSIMONYOUNG RVBRR: Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapy. Am J Med 63:177-182, 1977 Differences in response for different drug combinations are apparently explainable by tumor volume and sites of involvement. Patients with bone marrow or gastrointestinal involvement, or both, have the worst prognosis, whereas those with lymph node or soft-tissue involvement often achieve durable complete remissions despite extent of tumor. CrossrefMedlineGoogle Scholar40. JONESFUKSBULLKADINDORFMANKAPLANROSENBERGKIM SZMMRHSH: Non-Hodgkin's lymphomas. IV. Clinicopathologic correlation in 405 cases. Cancer 31:806-823, 1973 Clinicopathologic data on 405 patients with non-Hodgkin's lymphoma subsequently treated at the same institution. This paper, one of a series reporting extensive information on this large patient population, is well worth reading before the others. CrossrefMedlineGoogle Scholar41. CHABNERJOHNSONYOUNGCANELLOSHUBBARDJOHNSONDEVITA BRRGSSV: Sequential nonsurgical and surgical staging of non-Hodgkin's lymphoma. Ann Intern Med 85:149-154, 1976 Excellent review of 170 consecutive patients whose staging was evaluated sequentially. The authors note that in most cases of non-Hodgkin's lymphoma (80%) systemic disease can be identified without laparotomy. LinkGoogle Scholar42. ALBERTSDURIESALMON DBS: Doxorubicin/B.C.N.U. chemotherapy for multiple myeloma in relapse. Lancet 1:926-928, 1976 The first regimen apparently effective in treatment of patients in whom multiple myeloma has relapsed after standard chemotherapy. CrossrefMedlineGoogle Scholar43. ALEXANIANSALMONBONNETGEHANHAUTWEICK RSJEAJ: Combination therapy for multiple myeloma. Cancer 40:2765-2771, 1977 Rather good, extensive review of comparative studies of six different chemotherapeutic regimens in 462 previously untreated patients with multiple myeloma. Authors report the usefulness of vincristine when used with other agents. CrossrefMedlineGoogle Scholar44. CONKLINALEXANIAN RR: Clinical classification of plasma cell myeloma. Arch Intern Med 135:139-143, 1975 Evaluation of factors to help develop criteria for staging and define rational indications for chemotherapy in a large series of consecutive patients, with particular emphasis on patients with minimal disease. CrossrefMedlineGoogle Scholar45. SALMONWAMPLER SS: Multiple myeloma: quantitative staging and assessment of response with a programmable pocket calculator. Blood 49:379-389, 1977. Describes a method for calculating total body tumor burden based on M-component synthesis and metabolism and clinical staging of patients with myeloma. An interesting and useful approach. CrossrefMedlineGoogle Scholar46. BITRANDESSERDEMEESTERSHAPIROBILLINGSRUBENSTEINEVANSCOLMANRAOGRIEMGOLOMB JRTCALRMYMH: Combined modality therapy for stage IIIM0 non-oat cell bronchogenic carcinoma. Cancer Treat Rep 62:327-332, 1978 Results of a combined modality regimen incorporating radiation therapy to the primary tumor and regional lymph nodes plus combination chemotherapy. A remission rate of 43% to 57% is reported for the major non-small-cell forms of lung cancer and improved survival indicated for patients who respond. MedlineGoogle Scholar47. BUNNCOHENIHDEFOSSIECKMATTHEWSMINNA PMDBMJ: Advances in small cell bronchogenic carcinoma. Cancer Treat Rep 61:333-342, 1977. Brief but complete review of the revised histologic classification and natural history, as well as published results of treatment programs, for this form of lung cancer. MedlineGoogle Scholar48. LIVINGSTON R: Combination chemotherapy of bronchogenic carcinoma. I. Non-oat cell. Cancer Treat Rev 4:153-165, 1977 Detailed review of the status of chemotherapy for histologic types other than small-cell carcinoma. Whereas remission rates have apparently increased with drug combinations, there has been no overall improvement in long-term survival. Toxicity of previous regimens and its contribution to patient morbidity is emphasized. CrossrefMedlineGoogle Scholar49. MCKNEALLYMAVERKAUSEL MCH: Regional immunotherapy of lung cancer with intrapleural B.C.G. Lancet 1:377-379, 1976 Interesting initial report of a randomized trial of intrapleural BCG vaccine as an adjuvant treatment after resection of non-small-cell lung cancer. The authors report a significant improvement in survival of patients receiving this therapy. CrossrefMedlineGoogle Scholar50. GUNDERSON L: Radiation therapy: results and future possibilities. Clin Gastroenterol 5:743-776, 1976 Authoritative review of the rationale and the results of radiation therapy for gastrointestinal cancer. The author has analyzed the anatomic patterns of recurrent tumor after surgery with curative intent, with emphasis on the design of pre- or postoperative irradiation ports. CrossrefMedlineGoogle Scholar51. MOERTEL C: Clinical management of advanced gastrointestinal cancer. Cancer 36 (suppl):675-682, 1975 Concise but highly useful report of results of treatment programs conducted in the author's own institution, as well as those of trials being conducted by cooperative groups. CrossrefMedlineGoogle Scholar52. WOOLLEYMACDONALDSCHEIN PJP: Chemotherapy of malignancies of the gastrointestinal tract. Prog Gastroenterol 3:671-692, 1977 Comprehensive review of the current status of chemotherapy for advanced stages of disease and of surgical adjuvant therapy. Each major organ site in the gastrointestinal tract is discussed separately, with emphasis on results of recently completed controlled trials. Google Scholar53. MURPHY G (editor): Carcinoma of the prostate. Semin Oncol 3:101-197, 1976 An entire issue devoted to all aspects of prostate cancer. Google Scholar54. JAFFE N: Potential of combined modality approaches for the treatment of malignant bone tumors in children. Cancer Treat Rev 2:33-53, 1975 Comprehensive review of all tumors that originate in or affect bone. CrossrefMedlineGoogle Scholar55. SUITRUSSELLMARTIN HWR: Sarcoma of soft tissue: clinical and histopathologic parameters and response to treatment. Cancer 35:1478-1483, 1975 Detailed consideration of the role of histologic grading by number of mitoses and results of radiation therapy. CrossrefMedlineGoogle Scholar56. POSNER J: Management of central nervous system metastases. Semin Oncol 4:81-91, 1977 Comprehensive review by a very experienced neurologist of the management of all forms of central nervous system metastatic disease, including symptoms, diagnostic studies, and therapy. The author reviews the results of others, then presents his recommendations. MedlineGoogle Scholar57. SHELINE G: Radiation therapy of brain tumors. Cancer 39(suppl):873-881, 1977 The role of radiation therapy in management of each histologic type of brain tumor is discussed and the literature reviewed. CrossrefMedlineGoogle Scholar58. WILSONYORKELEVIN CCV: Intracranial malignant growth, primary and metastatic. Curr Probl Cancer 1:1-46, 1977 This clinically oriented review, especially valuable for the approach to primary central nervous system tumors by leaders in the field, shows excellent examples of abnormal computed tomography, correlated with gross pathologic specimens. Includes review of the roles of surgery, radiation therapy, and chemotherapy. CrossrefMedlineGoogle Scholar59. LEGHAVALDIVIESONELSONBENJAMINBODEY SMRRG: Chemotherapy for metastatic carcinoid tumors: experiences with 32 patients and a review of the literature. Cancer Treat Rep 61:1699-1703, 1977 Besides reviewing the literature describing the activity of single anticancer agents and combination chemotherapy, the authors report the potential usefulness of doxorubicin as a treatment for this endocrine tumor. MedlineGoogle Scholar60. MCCARTHY D: Report on the United States experience with cimetidine in Zollinger-Ellison syndrome and other hypersecretory states. Gastroenterology 74:453-458, 1978 Describes the results of cimetidine treatment of excessive gastrin secretion, including 60 patients with the Zollinger-Ellison syndrome. Recommendations for dose schedule, criteria for response, and toxicities are described in detail. CrossrefMedlineGoogle Scholar61. SCHEIN P Chemotherapy of gastrointestinal endocrine tumors. Excerpta Medica International Congress Series no. 403, Endocrinology 2:453-457, 1976 A comprehensive review of the therapeutic options for patients with islet cell tumors and malignant carcinoid tumors. Google Scholar62. BESARABCARO AJ: Mechanisms of hypercalcemia in malignancy. Cancer 41:2276-2285, 1978 A review of mechanisms including prostaglandins. CrossrefMedlineGoogle Scholar63. DOUGLASSSHUKLAMINDELL HSE: Treatment of pathological fractures of long bones excluding those due to breast cancer. J Bone Joint Surg (Am) 58:1055-1060, 1976 Report of the author's experience in 72 pathologic fractures associated with tumors. Useful for physicians who are reluctant to ask their orthopedic colleagues to aggressively treat pathologic fractures in patients with cancer. CrossrefMedlineGoogle Scholar64. GALASKO C: The pathological basis for skeletal scintigraphy. J Bone Joint Surg (Br) 57:353-359, 1975 A clinicopathologic correlation of necropsy specimens and skeletal scintigraphy in patients with a variety of tumors involving bone. The authors effectively show that scintigrams always reflect new bone formation. CrossrefMedlineGoogle Scholar65. GILBERTKAGENNUSSBAUMAROORSATZMANCHANBRENTFORSYTHE HAHRJPAA: Evaluation of radiation therapy for bone metastases: pain relief and quality of life. Am J Roentgenol 129:1095-1096, 1977 Evaluation of the effect of radiation therapy on pain relief and quality of life in 158 patients with pain related to bony involvement with tumor. Median survival for all patients after initial treatment for bone metastases was 1 year, emphasizing the value of significant palliation. CrossrefMedlineGoogle Scholar66. HIGBYHENDERSON DE: Granulocyte transfusion for infection during neutropenia. Semin Oncol 2:361-368, 1975 Review of the techniques of granulocytic transfusions. MedlineGoogle Scholar67. KETCHELRODRIGUEZ SV: Acute infections in cancer patients. Semin Oncol 5:167-180, 1978 A survey of microbiologic data in cancer patients. MedlineGoogle Scholar68. LEVINESCHIMPFFGRAWYOUNG ASRR: Hematologic malignancies and other marrow failure states: progress in the management of complicating infections. Semin Hematol 11:141-202, 1974 Detailed and thorough review of infectious complications in hematologic malignancies. MedlineGoogle Scholar69. O'REGANCARSONCHESNEYDRUMMOND SSRK: Electrolyte and acid-base disturbances in the management of leukemia. Blood 49:345-353, 1977 A complete review of hypokalemia and of lactic acidosis but without references. CrossrefMedlineGoogle Scholar70. PEREZPRESANTVAN AMBURG CCA: Management of superior vena cava syndrome. Semin Oncol 5:123-134, 1978 Recent review of the Washington University (St. Louis) experience; the low recurrence rate with radiation is noted. MedlineGoogle Scholar71. SCHEINMACDONALDWATERSHAIDAK PJCD: Nutritional complications of cancer and its treatment. Semin Oncol 2:337-347, 1975 A comprehensive discussion of the current concepts of the mechanism of the anorexia-cachexia syndrome and the contribution of anticancer treatment for the state of malnutrition. MedlineGoogle Scholar72. SISECRICHLOW JR: Obstruction due to malignant tumors. Semin Oncol 5:213-224, 1978 Comprehensive consideration of obstruction due to tumor and the diagnostic techniques available. MedlineGoogle Scholar73. SUNBOWIEKAZMIERELVEBACKOWEN NEFLC: Blood coagulation studies in patients with cancer. Mayo Clin Proc 49:636-641, 1974 Survey of blood clotting tests in cancer patients. A high incidence of abnormal test results is noted. MedlineGoogle Scholar74. WEICK J: Intravascular coagulation in cancer. Semin Oncol 5:203-212, 1978 Most recent review of disseminated intravascular coagulation in cancer. MedlineGoogle Scholar75. DUDRICKMACFADYENSOUCHONENGLERTCOPELAND SBEDE: Parenteral nutrition techniques in cancer patients. Cancer Res 37:2440-2450, 1977 Excellent review of a large experience at a major tumor institute using parenteral nutrition for cancer patients undergoing surgery, radiotherapy, and chemotherapy. MedlineGoogle Scholar76. CATALANO R: The medical approach to management of pain caused by cancer. Semin Oncol 2:379-392, 1975 Comprehensive review of the origins of pain and all methods of control, particularly useful because of its rather detailed listing of narcotics, their relative potency, duration of action, side-effects, and drug interactions, and other information useful to the practicing physician. MedlineGoogle Scholar77. MARKSSACHAR RE: Undertreatment of medical inpatients with narcotic analgesics. Ann Intern Med 78:173-181, 1973 This paper pointed out what many physicians concerned with pain had suspected: Difficulty controlling pain is more often related to prescribing habits of physicians than to unavailability of suitable narcotics. LinkGoogle Scholar78. PLANT J: Finding a home for hospice care in the United States. Hospitals 51(13):53-62, 1977 Description of the concepts of hospice programs, including the various types now in operation in the United States and abroad. A good overview. MedlineGoogle Scholar79. TWYCROSS R: Choice of strong analgesics in terminal cancer: diamorphine or morphine. Pain 3:93-104, 1977 The author (St. Christopher's Hospice, London), who has been the main advocate of the use of heroin, in this paper has compared the Brompton cocktail with either heroin or morphine in a double-blind controlled study and found no difference between them. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: AMERICAN COLLEGE OF PHYSICIANS Philadelphia, Pennsylvania*Vincent T. DeVita, M.D., Chairman; Paul Calabresi, M.D.; George P. Canellos, M.D.; Saul A. Rosenberg, M.D.; Philip S. Schein, M.D.; and John E. Ultmann, M.D.†Computer literature file of the National Library of Medicine, Bethesda, Maryland, Consulted through the Regional Medical Library service Library of the College of Physicians of Philadelphia, with the technical assistance of Ruthanne Henner. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 1 June 1979Volume 90, Issue 6Page: 996-1000KeywordsComputersLibraries ePublished: 1 December 2008 Issue Published: 1 June 1979 PDF downloadLoading ...